Icad Inc Reports Results For The Quarter Ended December 31: Earnings Summary

icad

19/03/2025 21:01

ICAD Inc ICAD.OQ reported a quarterly adjusted loss of 3 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 5 cents.  The mean expectation of four analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -8 cents to -2 cents per share.

Revenue rose 14.1% to $5.41 million from a year ago; analysts expected $4.83 million.

ICAD Inc's reported EPS for the quarter was a loss of 3 cents​.

The company reported a quarterly loss of $854 thousand.

ICAD Inc shares had risen by 26.8% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 19.2% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for ICAD Inc is $3.50

This summary was machine generated from LSEG data March 19 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.05
-0.03
Beat
Sep. 30 2024
-0.08
-0.07
Beat
Jun. 30 2024
-0.07
-0.06
Beat
Mar. 31 2024
-0.06
-0.05
Beat